TL Genomics Company
TL Genomics is a developer of a prenatal diagnosis technology created to isolate fetal nucleated red blood cells in maternal blood.
Technology:
Pregnancy biomarkers
Industry:
Molecular
Headquarters:
Koganei, Tokyo, Japan
Founded Date:
2015-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
4
Total Funding:
$3,800,000.00
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018-05-07
Last Funding Type:
Series B
Register and Claim Ownership